Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/detail.php on line 234

Warning: in_array() expects parameter 2 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 82

Warning: array_push() expects parameter 1 to be array, null given in /home/pharmalicensing/public_html/inc_stats.php on line 85
Pharmalicensing | Life Science's Global Technology Marketplace
Save this technology
close
Save to Existing Project
Save to a New Project
Inno-C08001 (Carvedilol CR)
Innopharmax Inc. Taiwan flag Taiwan
Abstract ID:
Inno-C08001 is indicated for the treatment of hypertension, heart failure and left ventricular dysfunction following myocardial infarction...
Contact Betty Tsai
Participants
You
Email me a copy of this message

Inno-C08001 is indicated for the treatment of hypertension, heart failure and left ventricular dysfunction following myocardial infarction. The active ingredient of Inno-C08001 is poorly soluble, especially in aqueous medium, which can limit the release and absorption of the drug in the gastrointestinal tract. Its immediate release formulation is given twice daily. Inno-C08001 is designed to enhance the solubility, and as an extended-release tablet, it is intended for once-daily administration.

Type of Business Relationship Sought
License out/Co-development
FEATURED
Last Updated Sep 2014
Technology Type THERAPEUTIC
Phase of Development EARLY STAGE
CORPORATION